73401-74-8

Basic information

• Product Name: 4-(HYDROXYMETHYL)PHENYLACETIC ACID
• Synonyms: 4-(Carboxymethyl)benzyl alcohol;2-(4-(hydroxyMethyl)phenyl)acetic acid;4-(Carboxymethyl)benzyl alcohol, [4-(Carboxymethyl)phenyl]methanol;4-(HydroxyMethyl)phenylacetic acid, 98%, 98%;4-(Hydroxymethyl)phenylacetic acid≥ 99% (GC);HO-PAM-LINKER;4-(HYDROXYMETHYL)PHENYLACETIC ACID;4-(2-HYDROXY-5-METHYLPHENYLAZO)ACETANILIDE
• CAS NO: 73401-74-8
• Molecular Formula: C₉H₁₀O₃
• Molecular Weight: 166.17
• Product Categories: Aromatic Phenylacetic Acids and Derivatives;C9;Carbonyl Compounds;Carboxylic Acids
• Mol File: 73401-74-8.mol

Chemical Properties

• Melting Point: 131-134 °C(lit.)
• Boiling Point: 357.841 °C at 760 mmHg
• Flash Point: 184.406 °C
• Appearance: /
• Density: 1.271 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.585
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.27±0.10(Predicted)
• CAS DataBase Reference: 4-(HYDROXYMETHYL)PHENYLACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(HYDROXYMETHYL)PHENYLACETIC ACID(73401-74-8)
• EPA Substance Registry System: 4-(HYDROXYMETHYL)PHENYLACETIC ACID(73401-74-8)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 73401-74-8(Hazardous Substances Data)

Usage

Chemical Properties

White solid

InChI:InChI=1/C9H10O3/c10-6-8-3-1-7(2-4-8)5-9(11)12/h1-4,10H,5-6H2,(H,11,12)

Upstream product

• 13737-36-5 4-bromophenylacetic acid 
• 622-47-9 4-tolylacetic acid 

Downstream Products

• 1312937-67-9 (E)-1-(4-(2-(piperidin-1-yl)vinyl)phenyl)ethan-1-one 
• 118618-41-0 [4-(hydroxymethyl)phenyl]acetic acid ethyl ester 
• 1146691-39-5 (4-benzooxazol-2-ylmethyl-phenyl)-methanol 
• 1146691-32-8 (4-benzothiazol-2-ylmethyl-phenyl)-methanol 
• 155380-11-3 methyl 4-(hydroxymethyl)phenylacetate 
• 34841-47-9 2-(4-formylphenyl)acetic acid 

Relevant articles and documents

Preparation method of netarsudil mesylate

The invention relates to a preparation method of netarsudil mesylate.Netarsudil mesylate is synthesized by utilizing chiral induction, and compared with an existing chiral HPLC method or SFC method, netarsudil mesylate prepared by adopting a chemical synt

Nitroxide derivative of ROCK kinase inhibitor

The invention provides a small molecular compound of a NO donor. The small molecular compound is characterized in that the small molecular compound is a compound shown represented by structural formula I shown in the description, or a stereoisomer, a geometrical isomer, a tautomer, a racemate, a deuterated isotope derivative, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof; and in the formula I, ring A is a substituted or unsubstituted heteroaromatic ring, X is selected from (CH2)n, n is selected from 0, 1, 2 and 3, R is a substituent group of terminal -O-NO2, R is selected from hydrogen, a hydroxyl group, halogen, an amino group, a cyano group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group and a substituted or unsubstituted heteroalkyl group, and R and R are respectively and independently selected from hydrogen, a substituted or unsubstituted alkyl group, a substituted or unsubstituted naphthenic base or an amino protecting group, or R and R are connected to form a substituted or unsubstituted cyclic heteroalkyl group. The compound has a high-activity inhibition effect on ROCK kinase.

Process for the preparation of kinase inhibitors and intermediates thereof

Described are processes for the synthesis of certain compounds, useful for treating diseases, e.g. eye disease, such as glaucoma and ocular hypertension, in a subject.

PROCESS FOR THE PREPARATION OF KINASE INHIBITORS AND INTERMEDIATES THEREOF

Described are processes for the synthesis of certain compounds, useful for treating diseases, e.g. eye disease, such as glaucoma and ocular hypertension, in a subject.

Preparation method of AR-13324

The invention relates to a preparation method of AR-13324. According to the invention, a chiral ligand is used for chiral induced synthesis of AR-13324. In comparison with an existing chiral HPLC method or a SFC method, the method of the invention has the

Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses

Compounds of formula (I) are provided: STR1 wherein: R1 represents an alkyl group; or a group of formula (II), (III), (IV) or (V): STR2 and wherein the groups R2, R3, R4 and R5 are hydrogen or various organic groups; and pharmaceutically acceptable salts thereof; as well as methods for the preparation of such compounds and their use in the treatment and prophylaxis of hypercholesteremia and arteriosclerosis.